RITA Medical Systems Announces Third Quarter 2006 Earnings Release Date and Conference Call
October 10 2006 - 5:30PM
PR Newswire (US)
Fremont, Calif., Oct. 10 /PRNewswire-FirstCall/ -- RITA Medical
Systems, Inc. (NASDAQ:RITA) today announced that it will release
financial results for the third quarter ended September 30, 2006,
after the market close on Tuesday, November 7, 2006. The Company
will also host a conference call and live audio webcast on Tuesday,
November 7, 2006 at 2:00 p.m. Pacific Time to discuss the Company's
third quarter results, outlook for the remainder of 2006, and
current corporate developments. The dial-in number for the
conference call is 800-257-1927 for domestic participants and
303-262-2075 for international participants. A live audio webcast
of the conference call will also be available at
http://www.ritamedical.com/. A taped replay of the conference call
will be available beginning approximately one hour after the call's
conclusion and will remain available for 7 days. It can be accessed
by dialing 800-405-2236 for domestic callers and 303-590-3000 for
international callers, both using the passcode 11073387#. An online
replay of the audio webcast will be available immediately following
the broadcast at http://www.ritamedical.com/. Webcast participants
are encouraged to go to the site at least 15 minutes prior to the
start of the call to register, download and install any necessary
audio software. About RITA Medical Systems, Inc. RITA Medical
Systems develops, manufactures and markets innovative products for
cancer patients including radiofrequency ablation (RFA) systems and
embolization products for treating cancerous tumors as well as
percutaneous vascular and spinal access systems. The Company's
oncology product lines include implantable ports, some of which
feature its proprietary Vortex(R) technology; tunneled central
venous catheters; and safety infusion sets and peripherally
inserted central catheters used primarily in cancer treatment
protocols. The radiofrequency product line also includes the HABIB
4X resection device which coagulates a "surgical resection plane"
and is designed to facilitate a fast dissection in order to
minimize blood loss and blood transfusion during surgery. The
proprietary RITA RFA system uses radiofrequency energy to heat
tissue to a high enough temperature to ablate it or cause cell
death. In March 2000, RITA became the first RFA company to receive
specific FDA clearance for unresectable liver lesions in addition
to its previous general FDA clearance for the ablation of soft
tissue. In October 2002, RITA again became the first company to
receive specific FDA clearance, this time for the palliation of
pain associated with metastatic lesions involving bone. The Company
also distributes LC Bead embolic microspheres in the United States.
The LC Bead microspheres are injected into selected vessels to
block the blood flow feeding a tumor, causing it to shrink over
time, and are often used in combination with radiofrequency
ablation (RFA). The RITA Medical Systems website is at
http://www.ritamedical.com/. The Company cautions that the planned
appearances of Company personnel, time and/or manner of the live
teleconference, webcast and replays may change for administrative
or other reasons outside the Company's control. DATASOURCE: RITA
Medical Systems, Inc. CONTACT: media, Steve DiMattia,
+1-646-277-8706, or , or investors, Doug Sherk, , or Jenifer
Kirtland, all of EVC Group, +1-415-896-6820, for RITA Medical
Systems, Inc.; or Stephen Pedroff, VP Marketing Communications of
RITA Medical Systems, Inc., +1-510-771-0400, or Web site:
http://www.ritamedical.com/
Copyright
Rita Medical (NASDAQ:RITA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rita Medical (NASDAQ:RITA)
Historical Stock Chart
From Jul 2023 to Jul 2024